2021 and older

Bombaci G,  Sarangdhar M,  Andina A,  Tardivel A,  Yu E,  Mackie GM, Pugh G,  Ozan VB,  Banz Y, Spinetti T,  Hirzel C,  Youd E,  Schefold JC,  Taylor GS,  Gazdhar A,  Bonadies N,  Angelillo-Scherrer A,  Schneider P,  Maslowski KM, Allam R. LRR protein RNH1 inhibits inflammasome activation through proteasome-mediated degradation of Caspase-1 and is associated with adverse clinical outcomes in COVID-19 patients (2021). BioRxiv :

Hallal M, Braga-Lagache S, Jankovic J, Simillion C, Bruggmann R, Uldry AC, Allam R, Heller M, Bonadies N. Inference of kinase-signaling networks in human myeloid cell line models by Phosphoproteomics using kinase activity enrichment analysis (KAEA). BMC Cancer. 2021 Jul 8;21(1):789. doi: 10.1186/s12885-021-08479-z. PMID: 34238254; PMCID: PMC8268341.

Sarangdhar MA, Allam R. Angiogenin (ANG)-Ribonuclease Inhibitor (RNH1) System in Protein Synthesis and Disease. Int J Mol Sci. 2021 Jan 28;22(3):1287. doi: 10.3390/ijms22031287. PMID: 33525475; PMCID: PMC7866052. (Review)

Chanias I, Stojkov K, Stehle GT, Daskalakis M, Simeunovic H, Njue LM, Schnegg-Kaufmann AS, Porret NA, Allam R, Rao TN, Benz R, Ruefer A, Schmidt A, Adler M, Rovo A, Balabanov S, Stuessi G, Bacher U, Bonadies N, On Behalf Of The Swiss Mds Study Group. Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine. Cancers (Basel). 2021 Jun 30;13(13):3296. doi: 10.3390/cancers13133296. PMID: 34209457; PMCID: PMC8267785.

Chennupati V, Veiga DF, Maslowski KM, Andina N, Tardivel A, Yu EC, Stilinovic M, Simillion C, Duchosal MA, Quadroni M, Roberts I, Sankaran VG, MacDonald HR, Fasel N, Angelillo-Scherrer A, Schneider P, Hoang T, Allam R. Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translation. J Clin Invest. 2018 Apr 2;128(4):1597-1614. doi: 10.1172/JCI94956. Epub 2018 Mar 19. PMID: 29408805; PMCID: PMC5873846.

For a complete list of publications